Study of ZIO-201 in Advanced Sarcoma

Phase 2CompletedNCT00439686

Alaunos Therapeutics53 enrolled

Overview

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

ZIO-201 given for 3 consecutive days to be repeated every 21 days for up to 6 months

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Metastatic and /or unresectable disease state after previous standard chemotherapy

Unnamed facility

Santa Monica, California, United States

Unnamed facility

Ann Arbor, Michigan, United States

toxicities

Time frame: 6 months

pharmacokinetics

Time frame: 6 months

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.